Vigor Peptides

Sale!

Tirzepatide 30mg (Single Vial)

Tirzepatide is a dual-agonist peptide currently under investigation in preclinical and experimental research settings for its interaction with incretin-related receptor pathways and metabolic signaling systems.

Third-party lab tested with Certificate of Analysis (COA)
Supplied as a lyophilized powder
In stock and ready to ship

Note: This product is intended for laboratory research use only. Not for human consumption.

Availability: In stock

Original price was: $299.00.Current price is: $259.00.

Availability: In stock

Purchase & earn 259 points!

Tirzepatide Peptide – Research Overview

Tirzepatide peptide is a synthetic dual-agonist compound currently under investigation in preclinical and experimental research settings. As a GLP-1/GIP agonist, it is characterized by its interaction with two incretin-related receptor pathways: glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR).

This dual-agonist profile positions Tirzepatide as a research peptide for exploring coordinated signaling across multiple pathways within metabolic signaling systems and energy regulation models under controlled laboratory conditions.

Mechanism Profile in Research Settings

The Tirzepatide research peptide is studied for its interaction across two receptor pathways:

GLP-1R Interaction – Examined within incretin-related signaling systems in controlled research environments

GIPR Interaction – Investigated in relation to broader metabolic signaling pathways and receptor-level response mechanisms

As a Tirzepatide GLP-1/GIP peptide, this dual-receptor activity supports evaluation of coordinated pathway interactions and signaling complexity in experimental models.

Because it engages both GLP-1R and GIPR together, Tirzepatide offers a more complete research framework compared to single-pathway peptides like Semaglutide.

Research Context

Tirzepatide compound research is conducted in controlled laboratory settings focused on dual-pathway signaling systems and receptor interaction models. The Tirzepatide molecule is frequently utilized in comparative research involving both single-pathway and multi-receptor agonist compounds.

All referenced information reflects controlled research environments and is provided strictly for scientific and educational context.

Why Researchers Explore Tirzepatide

The Tirzepatide dual-agonist peptide is studied for its ability to engage multiple receptor systems simultaneously. This supports:

  • Dual-receptor interaction studies
  • Comparative pathway analysis
  • Experimental metabolic signaling models

This makes the Tirzepatide 30mg single vial format suitable for structured laboratory investigations requiring consistent compound characterization across extended research applications.

Storage & Handling

  • Form: Lyophilized powder

  • Storage: –20°C in dry, light-free conditions until reconstitution

  • Stability: Maintains integrity for extended periods if stored correctly

  • Use: For laboratory research only; not for human or veterinary use

Compliance Statement

This product is provided exclusively for laboratory research. Any discussion of research context is intended for educational purposes only. We do not recommend or endorse use in humans or animals. Researchers should follow all applicable regulations and ethical guidelines.

 

Quality & Verification

Each batch of Tirzepatide peptide undergoes comprehensive third-party analytical testing to verify identity, purity, and quantity.

Additional testing includes:

  • Endotoxin analysis (LAL)
  • Sterility-related testing protocols

All testing is performed to support research-use characterization and batch consistency. A corresponding Certificate of Analysis (COA) is provided for each lot.

Ordering & Availability

Laboratories seeking to buy Tirzepatide 30mg can review current batch availability, third-party testing documentation, and transparent pricing directly on this page.

For those looking to buy Tirzepatide 30mg online, this single vial format supports extended research applications while maintaining consistent compound sourcing and verification standards.

Whether you are conducting small-scale studies or require larger-format quantities, the Tirzepatide 30mg single vial option provides flexibility for a range of controlled laboratory research needs.

Frequently Asked Questions

Q: Where can I buy Tirzepatide 30mg online?
A: Tirzepatide 30mg is available directly through this page, with each batch supported by third-party testing and a matching Certificate of Analysis (COA).

Q: Is Tirzepatide 30mg single vial tested and verified?
A: Yes. Each lot undergoes third-party analytical testing to confirm identity, purity, and quantity.

Q: What is the difference between 10mg and 30mg formats?
A: The 30mg single vial provides a higher quantity format, supporting extended research protocols while maintaining consistent compound characterization.

Summary

Tirzepatide peptide is a dual-agonist research compound characterized by its interaction with GLP-1R and GIPR receptor pathways. This dual-receptor profile supports the study of coordinated signaling across metabolic pathways and energy regulation systems in controlled laboratory environments.

The Tirzepatide 30mg single vial is supplied as a lyophilized powder and supported by third-party analytical testing, including verification of identity, purity, and quantity, with a corresponding Certificate of Analysis (COA) for each batch.

Introduction: Tirzepatide Peptide for Research

Tirzepatide peptide is a synthetic dual-agonist molecule developed for use in controlled laboratory environments. As a GLP-1/GIP receptor agonist, it engages two incretin-related signaling pathways, providing a model for studying multi-pathway interactions within metabolic signaling systems and energy regulation frameworks.

Researchers seeking to buy Tirzepatide 30mg often select this compound for its consistency, stability, and reproducibility in controlled experimental settings. Each 30mg vial of Tirzepatide lyophilized powder is third-party tested and supplied with a batch-matched Certificate of Analysis (COA) to support research-use verification.

Tirzepatide Peptide – Research Overview

Tirzepatide belongs to a class of incretin-based research peptides characterized by dual-receptor interaction:

GLP-1R (glucagon-like peptide-1 receptor) – Studied within incretin-related signaling pathways in controlled research environments

GIPR (glucose-dependent insulinotropic polypeptide receptor) – Investigated in relation to broader metabolic signaling systems

As a Tirzepatide GLP-1/GIP peptide, this dual-agonist structure supports the study of coordinated receptor activity and pathway interaction in experimental models.

Synonyms commonly referenced in research literature include:

  • Tirzepatide peptide
  • Tirzepatide dual-agonist
  • Tirzepatide research peptide
  • GLP-1/GIP agonist

Mechanism Profile in Research Models

GLP-1R Interaction

GLP-1 receptor interaction is examined within incretin-related signaling systems and pathway modeling in controlled environments.

GIPR Interaction

GIP receptor interaction is studied in relation to metabolic signaling pathways and receptor-level response mechanisms.

Dual-Agonist Framework

By engaging both receptor pathways simultaneously, Tirzepatide provides a framework for evaluating multi-pathway signaling and receptor interaction complexity. Comparative research often evaluates this dual-agonist profile alongside single-pathway compounds.

Research Context

Tirzepatide compound research is conducted in controlled laboratory settings focused on receptor interaction models and multi-pathway signaling systems. The Tirzepatide molecule is commonly utilized in comparative research involving both single-pathway and multi-receptor agonist compounds.

All referenced information reflects controlled research environments and is provided strictly for scientific and educational context.


Why Researchers Explore Tirzepatide Peptide

The Tirzepatide dual-agonist peptide is studied for its ability to engage multiple receptor systems simultaneously. This supports:

  • Dual-receptor interaction studies
  • Comparative pathway analysis
  • Experimental metabolic signaling models

The Tirzepatide 30mg single vial format supports structured laboratory investigations requiring extended research applications and consistent compound characterization.

Buying Tirzepatide 30MG Online

Laboratories seeking to buy Tirzepatide 30mg online can utilize the single vial format for extended research applications and reduced handling frequency.

  • Tirzepatide 30mg Single Vial – Suitable for extended research protocols

Additional formats may be available to support varying research needs.

Tirzepatide Price and Value

Tirzepatide pricing may vary depending on format and supplier standards. At Vigor Peptides, pricing is structured to remain transparent while maintaining strict quality control.

Each vial includes:

  • Third-party analytical testing
  • Batch-matched Certificate of Analysis (COA)
  • Secure, stability-conscious packaging
  • Lyophilized powder format for research storage

Tirzepatide Powder: Storage and Handling

Form
Lyophilized powder, 30mg per vial

Storage
Store at -20°C in a dry, moisture-free environment until reconstitution

Stability
Maintains integrity for extended periods when stored as directed

Handling
Reconstitution should follow standard laboratory protocols

Use
For research purposes only. Not for human or veterinary use

Technical Details

Name: Tirzepatide peptide
Form: Lyophilized powder
Quantity: 30mg per vial

Synonyms:
Tirzepatide peptide
Tirzepatide research peptide
Tirzepatide dual-agonist
GLP-1/GIP agonist

Applications:
Investigated in metabolic signaling and receptor interaction research models

Testing:
Third-party tested for identity, purity, and quantity
Endotoxin analysis (LAL)
Sterility-related testing protocols

Availability:
Single vial format

Compliance Statement

This product is offered strictly for laboratory research use only (RUO). It is not intended for human consumption, medical use, or diagnostic applications. Any discussion of research context is provided solely for educational purposes. Researchers are expected to follow all applicable regulations, ethical guidelines, and laboratory best practices.

 

Conclusion: Tirzepatide 30MG for Laboratory Research

Tirzepatide peptide is a dual-agonist research compound characterized by its interaction with GLP-1R and GIPR receptor pathways. This structure supports the study of coordinated signaling across metabolic systems and multi-pathway models in controlled laboratory environments.

The Tirzepatide 30mg single vial is supplied as a lyophilized powder and supported by third-party analytical testing, including verification of identity, purity, and quantity, with a corresponding Certificate of Analysis (COA) for each batch.

Researchers can order Tirzepatide 30mg online with access to verified quality standards, transparent pricing, and a format designed to support extended laboratory research applications.

Research use disclaimer
Scroll to Top